Celltech lifted by patent returns Celltech, the UK's largest biotechnology group, reported a 24 per cent increase in turnover for the first four months of the year, with strong growth in royalty income from its portfolio of patents. Medisys to move into profit in second half Medisys, the safety syringe maker, said on Thursday that it would move into profitability in the second half, after reporting a widening interim loss. Aortech's heart monitor gains marketing muscle Aortech, the medical technology company, has signed a distribution agreement for its first product, a heart monitor, with Becton Dickinson, the US medical devices company. Shown in local currency and time. Click through for full tearsheet.
Some Asian stocks are secondary listings.